arrow
Back
M

Michael H. Silverman

university of calgary

24H-index
91Paper Count
2.3KCitation Count
Published Papers 27
Publication Date
An open-label pilot study of psilocybin-assisted therapy for binge eating disorder
err2026-01-03
err0
errOAAI
errJesse Dallery; Jennifer L. Miller; Jeff Boissoneault; Lauren Harvey; Lindsey Ives; Alexandra Knerr; Shelby Blaes; Morgan N. Ransom; Melissa Munson; James P. Gilligan; Michael H. Silverman; Peter R. Guzzo; Beverlee Loeser
errShare
errSave
A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogens
err2025-11-06
err0
errOAAI
errMia Urem; Annemieke H. Friggen; Nina Musch; Michael H. Silverman; Christopher J. Swain; Michael R. Barbachyn; Lawrence I. Mortin; Xiang Yu; Robert J. DeLuccia; Meindert H. Lamers; Wiep Klaas Smits
errShare
errSave
Extended-duration dexamethasone for the treatment of hospitalized COVID-19 patients in Canada: A randomized clinical trial
err2025-10-01
err0
PREAI
errShechtman, Liran; Murthy, Srinivas; Tremblay, Alain; Silverman, Michael; Lee, Todd C.; Daley, Peter; Pinto, Ruxandra; Fowler, Robert A.
errShare
errSave
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study
err2025-06-01
err0
errOAAI
errTaryn A Eubank; Jinhee Jo; M Jahangir Alam; Khurshida Begum; Jacob K McPherson; ThanhPhuong M Le; Thomas D Horvath; Sigmund J Haidacher; Eugene C Poggio; Rong Lin; Corinne Seng Yue; Murray P Ducharme; Georges Koudssi; Julie Mercier; Jeffrey D Alder; Michael H Silverman; Kevin W Garey
errShare
errSave
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
err2024-09-01
err2
errOAAI
errZhanel, George; Silverman, Michael; Malhotra, Janhavi; Baxter, Melanie; Rahimi, Reza; Irfan, Neal; Girouard, Gabriel; Dhami, Rita; Kucey, Melissa; Stankus, Vida; Schmidt, Kristin; Poulin, Sebastien; Connors, William; Tascini, Carlo; Walkty, Andrew; Karlowsky, James
errShare
errSave
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT-1)
err2024-01-26
err9
errOAAI
errPapp, K. A.; Beyska-Rizova, S.; Gantcheva, M. L.; Slavcheva Simeonova, E.; Brezoev, P.; Celic, M.; Groppa, L.; Blicharski, T.; Selmanagic, A.; Kalicka-Dudzik, M.; Calin, C. A.; Trailovic, N.; Ramon, M.; Bareket-Samish, A.; Harpaz, Z.; Farbstein, M.; Silverman, M. H.; Fishman, P.
errShare
errSave
Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepaatoprotective effects
err2023-02-13
err10
errOAAI
errFishman, Pnina; Stemmer, Salomon M.; Bareket-Samish, Avital; Silverman, Michael H.; Kerns, William D.
errShare
errSave
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection
err2022-08-16
err8
errOAAI
errMcPherson, Jacob; Hu, Chenlin; Begum, Khurshida; Wang, Weiqun; Lancaster, Chris; Gonzales-Luna, Anne J.; Loveall, Caroline; Silverman, Michael H.; Alam, M. Jahangir; Garey, Kevin W.
errShare
errSave
A Time Series Analysis Evaluating Antibiotic Prescription Rates in Long-Term Care during the COVID-19 Pandemic in Alberta and Ontario, Canada
err2022-07-26
err2
errOAAI
errHaverkate, Manon R.; Macfadden, Derek R.; Daneman, Nick; Leal, Jenine; Otterstatter, Michael; Mahdavi, Roshanak; D'Souza, Adam G.; Rennert-May, Elissa; Silverman, Michael; Schwartz, Kevin L.; Morris, Andrew M.; Saatchi, Ariana; Patrick, David M.; Marra, Fawziah
errShare
errSave
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
err2022-02-04
err20
errOAAI
errGarey, Kevin W.; McPherson, Jacob; Dinh, An Q.; Hu, Chenlin; Jo, Jinhee; Wang, Weiqun; Lancaster, Chris K.; Gonzales-Luna, Anne J.; Loveall, Caroline; Begum, Khurshida; Alam, M. Jahangir; Silverman, Michael H.; Hanson, Blake
errShare
errSave
Editorial: targeting aberrant hepatic inflammation for treatment of non-alcoholic steatohepatitis-authors' reply
err2022-01-28
err0
errOAAI
errSafadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev-Cohain, Naama; Bareket-Samish, Avital; Silverman, Michael H.; Fishman, Pnina
errShare
errSave
Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis
err2021-10-20
err24
errOAAI
errSafadi, Rifaat; Braun, Marius; Francis, Adi; Milgrom, Yael; Massarwa, Muhammad; Hakimian, David; Hazou, Wadi; Issachar, Assaf; Harpaz, Zivit; Farbstein, Motti; Itzhak, Inbal; Lev-Cohain, Naama; Bareket-Samish, Avital; Silverman, Michael H.; Fishman, Pnina
errShare
errSave
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects
err2020-09-06
err15
errOAAI
errGarey, Kevin W.; Begum, Khurshida; Lancaster, Chris; Gonzales-Luna, Anne; Dinh Bui; Mercier, Julie; Yue, Corinne Seng; Ducharme, Murray P.; Hu, Ming; Vince, Bradley; Silverman, Michael H.; Alam, M. Jahangir; Kankam, Martin
errShare
errSave
Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer
err2020-09-01
err2
errOAAI
errGouda, M. A.; Sherman, E. J.; Gilcrease, G. W.; Vaishampayan, U. N.; Parikh, A.; Feun, L.; Kummar, S.; Huang, H.; Zhang, C.; Severson, P.; Inokuchi, K.; Silverman, M.; Bollag, G.; Janku, F.
errShare
errSave
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections
err2019-08-01
err35
errOAAI
errXu, Wei-Chu; Silverman, Michael H.; Yu, Xiang Yang; Wright, George; Brown, Neal
errShare
errSave
A Phase Ib/IIa study of the BET bromodomain inhibitor ZEN-3694 in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC)
err2019-07-01
err4
PREAI
errAggarwal, Rahul; Abida, Wassim; Schweizer, Michael; Pantuck, Allan; Nanus, David; Heath, Elisabeth; Lakhotia, Sanjay; Hansen, Henrik; Silverman, Michael; Bauman, Lisa; Snyder, Margo; Campeau, Eric; Norek, Karen; Attwell, Sarah; O'Farrell, Marie; Smith, Steve; Wegge, Philip; Jahagirdar, Ravi; Alumkal, Joshi
errShare
errSave
Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler
err2019-01-15
err8
errOAAI
errPerry, Jason; Trautman, Brian; Takher-Smith, Joe; Kramer, Steve; Kane, Katie; Silverman, Michael; Tan, Lisa; Haughie, Scott; Richter, Wolfram; Kirkov, Valentin; Arsova, Sacha; Ward, Jonathan; Hava, David L.
errShare
errSave
Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
err2018-08-29
err84
PREAI
errPantuck, Allan J.; Lee, Dong-Keun; Kee, Theodore; Wang, Peter; Lakhotia, Sanjay; Silverman, Michael H.; Mathis, Colleen; Drakaki, Alexandra; Belldegrun, Arie S.; Ho, Chih-Ming; Ho, Dean
errShare
errSave
Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson
err2018-01-01
err30
errOAAI
errCohen, Shira; Barer, Faina; Itzhak, Inbal; Silverman, Michael H.; Fishman, Pnina
errShare
errSave